Caricamento...
Biosimilar medicines
Biological medicines have become indispensable in the treatment of patients with serious diseases such as cancer and inflammatory diseases. Biosimilars are medicines which are developed to be similar to existing biological medicines (the ‘reference product’). For the European market, they are approv...
Salvato in:
| Pubblicato in: | Eur J Hosp Pharm |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Publishing Group
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452401/ https://ncbi.nlm.nih.gov/pubmed/31157111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-001821 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|